PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9178303

Microbial interactions with catheter material.

W J Lewis·R J Sherertz
View original source ↗Export metadata ↓

Abstract

The use of central venous catheters to deliver parenteral nutrition therapy is often complicated by infection. The original source of these infections has been debated but it appears that organisms colonizing the skin or those contaminating the catheter hub are most often responsible. Before forming a biofilm, an organism must first successfully attach to a surface. To do this, microbes have evolved strategies that allow them to adhere to surfaces and evade forces that would favor their detachment. Once a biofilm is formed on a catheter, the organisms are relatively safe from a host immune response and antibiotics. In this review, what is known about these interactions is discussed.

Explore related subjects

Bacterial InfectionsBiofilmsCandidiasisCatheterization, Central VenousEquipment ContaminationHumansStaphylococcal InfectionsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W J Lewis, R J Sherertz. 1997. Microbial interactions with catheter material.. https://doi.org/10.1016/s0899-9007(97)00215-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Epidemiology and management of infections after lung transplantation.

Lung transplantation has become an accepted treatment for end-stage pulmonary parenchymal and vascular diseases. Infections still are the most common cause of early and late morbidity and mortality in lung transplant recipients. Bacterial infections comprise approximately half of all infectious complications. Cytomegalovirus (CMV) infections and disease have become less frequent, because of prophylaxis with ganciclovir. Because CMV is also involved in the pathogenesis of obliterative bronchiolitis, the frequency of this infection may also reduce the occurrence of this main obstacle to successful lung transplantation. Invasive fungal infections remain a problem, but they have also decreased in frequency because of better control of risk factors such as CMV disease and preemptive antifungal therapy. Nonherpes respiratory viral infections have emerged as a serious problem. Their severity may be reduced by treatment with ribavirin. Meticulous postoperative surveillance, however, is still crucial for the management of lung transplant patients with respect to early detection and treatment of rejection and infection.

Bacterial Infections↗
PubMed2001

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.

This article contains highlights of "Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients: Recommendations of the CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation," which was published in the Morbidity and Mortality Weekly Report. There are sections on the prevention of bacterial, viral, fungal, protozoal, and helminth infections and on hospital infection control, strategies for safe living following transplantation, immunizations, and hematopoietic stem cell safety. The guidelines are evidence-based, and prevention strategies are rated by both the strength of the recommendation and the quality of evidence that supports it. Recommendations are given for preventing cytomegalovirus disease with prophylactic or preemptive gancyclovir, herpes simplex virus disease with prophylactic acyclovir, candidiasis with fluconazole, and Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole. Hopefully, following the recommendations made in the guidelines will reduce morbidity and mortality from opportunistic infections in hematopoietic stem cell transplant recipients.

Bacterial Infections↗
PubMed2001

Rapid identification of bacteria and yeast: summary of a National Committee for Clinical Laboratory Standards proposed guideline.

Using colony morphology on selected agars, Gram-stain morphology, and a number of 1-step biochemical or enzymatic tests, skilled microbiologists can identify the species of the majority of isolates seen routinely in a clinical laboratory. These results are often available more quickly than and are as accurate as those derived from conventional methods. The National Committee for Clinical Laboratory Standards has produced a guideline that describes tests that can be used to identify a number of aerobic gram-negative rods and gram-positive cocci, a number of commonly isolated anaerobes, and 3 species of yeast. An overview of the organisms included in the guideline, the tests that identify them, and the situations in which rapid testing is appropriate is presented here.

Bacterial Infections↗